Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® > Chinese Markets for Anti-Obesity Drugs
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

Chinese Markets for Anti-Obesity Drugs

¸®¼­Ä¡»ç Asia Market Information & Development
¹ßÇàÀÏ 2009³â 04¿ù »óǰÄÚµå 86346
ÆäÀÌÁö Á¤º¸ 180 Pages
°¡°Ý
US $ 4,000 £Ü 4,766,000 PDF by E-mail (Single User License)
US $ 8,000 £Ü 9,532,000 PDF by E-mail (Corporate Use License)


¿µ¹®¸ñÂ÷

Abstract

China' s demand for Anti-Obesity Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts through 2013 and 2018 are presented. Major producers in China are profiled.

Table of Contents

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II.BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
    • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

  • Anti-Obesity Drugs Industry Structure
    • Market Size
    • Market Growth Drivers
    • Anti-Obesity Drugs Industry Capacity
    • Major Producer Facility Locations and Output
    • Locations
    • Output
    • Market Share of Key Producers
    • Labor Cost
    • Potential Entrants
    • Major Distributors
    • Major Foreign Investments
    • Technology Development

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Overview
    • Demand of Anti-Obesity Drugs by Region
    • Anti-Obesity Drugs Production and Demand
    • Sibutramine
    • Major Manufacturers
    • Supply and Demand
    • Traditional Chinese Medicine
    • Major Manufacturers
    • Supply and Demand
    • Orlistat
    • Major Manufacturers
    • Supply and Demand
    • Rimonabant
    • Major Manufacturers
    • Supply and Demand
    • Metformin
    • Major Manufacturers
    • Supply and Demand
    • Other Anti-Obesity Drugs
    • Anti-Obesity Drugs Imports and Exports
    • Anti-Obesity Drugs Imports
    • Anti-Obesity r Drugs Exports
    • Pricing Trend

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Anti-Obesity Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China' s Distribution System
  • Cough Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China' s Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. ANTI-OBESITY DRUGS PRODUCER DIRECTORY

  • Profiles of Anti-Obesity Drugs Producers and Major Suppliers

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ANTI-OBESITY TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Anti-Obesity Drugs Industry Output
  • Major Producer Facility Location
  • Major Anti-Obesity Drugs Producer Output in 2007
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Anti-Obesity Drugs Production and Demand
  • Demand of Anti-Obesity Drugs by Region in 2004
  • Major Sibutramine Producer Output and Capacity in 2007
  • Sibutramine Drugs Production and Demand
  • Major Traditional Chinese medicine Producer Output and Capacity in 2007 Traditional Chinese Medicine Production and Demand
  • Major Orlistat Producer Output and Capacity in 2007
  • Olistat Production and Demand
  • Rimonabant Production and Demand
  • Major Metformin Producer Output and Capacity in 2007
  • Metformin Production and Demand
  • Other Anti-obesity Drugs Production and Demand
  • China Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Anti-Obesity Drugs Industry Output
  • Major Producer Facility Location
  • Major Anti-Obesity Drugs Producer Output in 2007
  • Market Share of Key Producers in 2007
  • Major Foreign Investment in China

LIST OF CHARTS

I. INTRODUCTION

  • China' s Anti-Obesity Drugs Capacity, Output, Demand

II. BUSINESS ENVIRONMENT

  • China' s GDP and Growth Rate
  • Industrial Output by Ownership
  • China' s Imports and Exports

III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

  • Anti-Obesity Drugs Capacity in China
  • All kinds of Anti-Obesity Drugs Market Share
  • Anti-Obesity Drugs Capacity, Output and Demand

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Total Anti-Obesity Drugs Production and Demand
  • Total Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Anti-Obesity Drugs Demand by Market in 2009

VI. MARKETING STRATEGIES

  • China' s Distribution Channel
Back to Top